Who is sponsoring NCT04699539?

NCT04699539 is sponsored by Changhai Hospital.

What drugs are being tested in NCT04699539?

Interventions: SBRT, Chemotherapy.

What is the status of NCT04699539?

NCT04699539 is currently COMPLETED.

Last reviewed 2025-12-10 · How we verify

Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer

NCT04699539 NA COMPLETED Results posted

The purpose of this study is to compare the efficacy and safety of a recurrence-pattern-based-volume versus conventional-volume stereotactic body radiation therapy for locally advanced pancreatic cancer, so as to determine whether the target delineation method based on recurrence pattern can obtain better survival benefits.

Details

Lead sponsor	Changhai Hospital
Phase	NA
Status	COMPLETED
Enrolment	96
Start date	Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Aug 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Treatment

Interventions

SBRT
Chemotherapy

Countries

China